Gerry Brunk (Lumira)

What will Lu­mi­ra Ven­tures do with $220M? Stay out of the com­fort zone and off the beat­en biotech path

Lu­mi­ra Ven­tures closed its largest fund on Mon­day, rak­ing in $220 mil­lion to pump in­to the life sci­ences — but in­stead of tar­get­ing biotech hubs like San Fran­cis­co and Boston, the com­pa­ny is rolling the dice on “un­der­served ge­o­gra­phies” in the US and Cana­da.

“We find of­ten­times com­pa­nies lo­cat­ed in places like Mon­tre­al, or Fort Laud­erdale, FL, or Kansas City or Phoenix, AZ just have more cap­i­tal ef­fi­cien­cy and bet­ter val­u­a­tions, with­out hav­ing to com­pro­mise any­thing at all in the qual­i­ty of the in­no­va­tion and the man­age­ment tal­ent,” co-founder and man­ag­ing part­ner Ger­ry Brunk told End­points News. 

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.